GWTI GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES
Industrial Organic Chemicals · OTC · SEC CIK 1572386 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY94.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-420.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets510,697.3%
Debt / equity—
Current ratio0.00x
Interest coverage-3.21x
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio-104.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $0 | $113,702 | $19,033 | $379,546 | $364,496 | $318,500 | $142,793 | $25,000 |
| SG&A expense | $236,778 | $564,682 | $275,866 | $374,820 | $990,360 | $733,518 | $389,349 | $229,768 |
| Operating income | -$236,778 | -$678,384 | -$294,899 | -$754,366 | -$1.35M | -$1.05M | -$532,142 | -$254,768 |
| Interest expense | $164,118 | $148,028 | $149,233 | $150,994 | $156,009 | $154,633 | $151,499 | — |
| Net income | -$400,896 | -$826,412 | -$444,132 | $1.44M | -$1.51M | -$1.21M | -$683,641 | -$410,942 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 464.87M | 462.58M | 461.89M | — | 454.36M | 453.64M | 437.70M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $122 | $461 | $7,271 | $850 | $36,632 | $379,959 | $169,832 | $20,139 |
| Current assets | $3,061 | $3,400 | $51,375 | $46,753 | $105,485 | $457,461 | $221,456 | $20,251 |
| Total assets | $3,061 | $3,400 | $51,375 | $46,753 | $105,485 | $457,461 | $221,456 | $20,251 |
| Current liabilities | $15.63M | $15.23M | $14.52M | $14.13M | $15.72M | $14.56M | $13.44M | $13.03M |
| Total liabilities | $15.63M | $15.23M | $14.52M | $14.13M | $15.72M | $14.56M | $13.44M | $13.03M |
| Shareholders' equity | -$15.63M | -$15.23M | -$14.47M | -$14.08M | -$15.61M | -$14.10M | -$13.21M | -$13.01M |
| Shares outstanding | 464.87M | 464.87M | 462.36M | 456.36M | 454.36M | 454.36M | 445.33M | 430.84M |
| Cash flow statement | ||||||||
| Operating cash flow | -$28,106 | -$53,635 | -$53,579 | -$35,782 | -$338,327 | -$9,873 | -$326,307 | -$188,195 |
| Financing cash flow | $27,767 | $46,825 | $60,000 | $0 | -$5,000 | $220,000 | $476,000 | $92,900 |
Free plan shows the latest 8 periods; Pro shows all 57 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.